Enanta Pharmaceuticals In...

NASDAQ: ENTA · Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT

Enanta Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-22.64M -22.29M -28.82M -22.66M -31.16M -33.41M -28.11M -39.06M -37.66M -28.99M -26.35M -31.7M -33.59M -30.11M -24.6M -24.02M -22.05M -8.33M
Depreciation & Amortization
2.65M 889K 479K 594K 621K 642K 669K 651K 540K 511K 655K 716K 822K 780K 806K 823K 834K 871K
Stock-Based Compensation
4.69M 5.67M 7.72M 5.42M 5.56M 8.1M 6.72M 7M 7.36M 7.14M 6.83M 7.6M 6.47M 6.06M 5.35M 5.47M 5.28M 4.88M
Other Working Capital
1.7M 1.8M 8.72M 2.68M 1.45M -6.27M 4.85M 290K 5.57M -11.01M 274K -522K -7.25M 15.66M 282.85M 292.53M 401.6M 1.05M
Other Non-Cash Items
-293K -1.18M 1.06M -823K -279K 786K -7.17M 519K -1.04M -339K -30K 146K 54K -474K -71K -2.19M -213K -1.02M
Deferred Income Tax
n/a n/a n/a n/a n/a 274K 79K -1.45M n/a n/a n/a n/a n/a 546K 345K 560K 525K 431K
Change in Working Capital
2.11M 113K 9.16M 2.69M -3.35M -1.38M 6.21M -1.23M 17.01M -13.97M 3.36M -6.37M -130K 9.93M -2.85M -10.15M 11.04M -11.72M
Operating Cash Flow
-13.49M -16.8M -10.4M -14.78M -28.6M -24.99M -21.6M -32.13M -13.78M -35.64M -15.53M -29.6M -26.38M -13.27M -21.02M -29.51M -4.58M -14.89M
Capital Expenditures
-2.54M -8.74M -8.95M -6.54M -1.67M -787K -1.37M -2.15M -2.38M -3.16M -1.44M -251K -74K -363K -33K -399K -130K -188K
Cash Acquisitions
n/a n/a n/a n/a n/a 12.33M n/a 143.6M -49.15M -36.73M -29.67M -16.47M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-55.02M n/a 1K -95.15M -65.29M -146.84M -106.12M -176.65M -23.25M -67.38M -8.73M -38.08M -61.73M -62.9M 601K -136.36M -66.91M -104.67M
Sales Maturities Of Investments
53.19M 77.65M 28.02M 95.35M 125.58M 134.51M 119.32M 33.05M 72.4M 104.1M 38.4M 54.55M 26.75M 108.77M 72.11M 93.06M 92.5M 87.42M
Other Investing Acitivies
n/a n/a n/a n/a n/a -12.33M n/a n/a 49.15M 36.73M 29.67M 16.47M -34.98M 45.86M 72.72M -43.31M 25.59M -17.26M
Investing Cash Flow
-4.37M 68.9M 19.07M -6.34M 58.62M -13.12M 11.84M -145.75M 46.77M 33.57M 28.23M 16.22M -35.05M 45.5M 72.68M -43.7M 25.46M -17.45M
Debt Repayment
n/a -4.94M -7.26M n/a n/a -7.17M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a -183K n/a n/a n/a n/a -1K n/a n/a n/a n/a -534K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-6.89M -137K -19K -6.67M -6.46M -183K -23K 199.88M -2.03M 301K 2.93M 4.12M 3.35M 9.63M 943K 686K 1.15M 299K
Financial Cash Flow
-6.89M -4.99M -7.21M -6.65M -6.41M -7.35M -23K 199.88M -2.03M 301K 2.93M 4.12M 3.35M 9.63M 943K 686K 1.15M 299K
Net Cash Flow
-24.74M 47.12M 1.46M -27.77M 23.61M -45.45M -9.79M 22M 30.95M -1.77M 15.63M -9.26M -58.08M 41.86M 52.6M -72.53M 22.03M -32.04M
Free Cash Flow
-16.03M -25.55M -19.35M -21.32M -30.27M -25.77M -22.97M -34.28M -16.17M -38.8M -16.97M -29.85M -26.45M -13.63M -21.05M -29.91M -4.71M -15.08M